Clinical Trials on Moderate Essential Hypertension
Total 12354 results
-
GlaxoSmithKlineCompleted
-
IlDong Pharmaceutical Co LtdCompletedEssential HypertensionKorea, Republic of
-
Aarhus University Hospital SkejbyAarhus University Hospital; Regional Hospital Holstebro; Regionshospitalet Silkeborg and other collaboratorsCompleted
-
Boryung Pharmaceutical Co., LtdAsan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Dong-A University and other collaboratorsCompleted
-
Chengdu University of Traditional Chinese MedicineHunan University of Traditional Chinese MedicineCompleted
-
University of JohannesburgCompletedEssential HypertensionSouth Africa
-
University of PaviaCompletedEssential Hypertension
-
TSH Biopharm Corporation LimitedCompleted
-
Novartis PharmaceuticalsCompletedEssential HypertensionTaiwan, Japan, Hong Kong, Thailand, Philippines, China, Korea, Republic of
-
Regional Hospital HolstebroCompletedThe Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables (hass)Essential HypertensionDenmark
-
Boryung Pharmaceutical Co., LtdPusan National University Hospital; Asan Medical Center; Chonnam National University... and other collaboratorsCompleted
-
St George's, University of LondonTerminated
-
StendoUnknownEssential HypertensionFrance
-
Shanghai Shyndec Pharmaceutical Co., Ltd.Unknown
-
Third Military Medical UniversityUnknown
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
HK inno.N CorporationUnknownEssential HypertensionKorea, Republic of
-
Quantum Genomics SACompletedEssential HypertensionFrance
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Terminated
-
Boryung Pharmaceutical Co., LtdPusan National University Hospital; Ulsan University Hospital; Daegu Catholic... and other collaboratorsCompletedHypertensionKorea, Republic of
-
University of AthensCompleted
-
NovartisCompleted
-
NovartisCompleted
-
Ahn-Gook Pharmaceuticals Co.,LtdUnknownEssential HypertensionKorea, Republic of
-
NovartisCompletedHypertensionSlovakia, Italy, Netherlands, Argentina, Germany, Poland, Czech Republic, Iceland
-
NovartisCompletedEssential HypertensionGermany, Spain, United States
-
sigma-tau i.f.r. S.p.A.Completed
-
Novartis PharmaceuticalsCompletedHypertensionSweden, United States, Peru, Russian Federation, Romania, Mexico, Panama, Spain, Denmark, Italy, Greece, South Africa, Canada, Argentina, Australia, Colombia, Finland, Taiwan
-
Yonsei UniversityCompletedEssential HypertensionKorea, Republic of
-
TakedaCompleted
-
Sankyo Pharma GmbhCompletedEssential HypertensionFrance, Austria, Switzerland, Belgium, Germany, Italy, Netherlands, United Kingdom, Portugal
-
Daiichi Sankyo, Inc.Shanghai Sankyo Pharmaceuticals Co., Ltd.CompletedEssential HypertensionChina
-
Daiichi Sankyo, Inc.Shanghai Sankyo Pharmaceuticals Co., Ltd.Completed
-
Boryung Pharmaceutical Co., LtdCompleted
-
Boryung Pharmaceutical Co., LtdSeoul National University Hospital; Kyungpook National University HospitalCompleted
-
Boryung Pharmaceutical Co., LtdCompleted
-
Boryung Pharmaceutical Co., LtdCompleted
-
Daiichi Sankyo, Inc.Daiichi Sankyo Taiwan Ltd.Completed
-
Hanmi Pharmaceutical Company LimitedCompletedHypertensionKorea, Republic of
-
Boryung Pharmaceutical Co., LtdCompleted
-
Daiichi Sankyo, Inc.Completed
-
Addrenex Pharmaceuticals, Inc.CompletedA Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential HypertensionHypertensionUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
AstraZenecaCompleted
-
NovartisCompleted
-
Pacific PharmaceuticalsUnknownEssential HypertensionKorea, Republic of
-
NovartisCompleted
-
National Taiwan University HospitalUnknown